2494 DTD-like
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Organic acids and derivatives | 6 | 1.5 | 3.93× | not tested | |
| Nucleosides, nucleotides, and analogues | 4 | 2.7 | 1.47× | not tested | |
| Homogeneous non-metal compounds | 3 | 2.1 | 1.41× | not tested | |
| Benzenoids | 1 | 0.7 | 1.39× | not tested | |
| Homogeneous metal compounds | 6 | 4.8 | 1.24× | not tested | |
| Organic oxygen compounds | 1 | 2.0 | 0.51× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04024 | A3S | Serine-3'-aminoadenosine | 20 |
| DB16833 | ADP | Adenosine disphosphate | 13 |
| DB03929 | DSN | D-Serine | 4 |
| DB04742 | NCF | (2R)-2-{(1R)-2-oxo-1-[(2-thienylacetyl)amino]ethyl}-5,6-dihydro-2h-1,3-thiazine-4-carboxylic acid | 4 |
| DB02517 | DGL | D-Glutamic Acid | 2 |
| DB03252 | DLY | D-Lysine | 2 |
| DB03355 | TSB | 5'-O-(L-Threonylsulfamoyl)adenosine | 2 |
| DB03869 | SSA | 5'-O-(L-Serylsulfamoyl)adenosine | 2 |
| DB04027 | DAR | D-arginine | 2 |
| DB00133 | SER | Serine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 30 |
| A3S | SERINE-3'-AMINOADENOSINE | 20 |
| A3T | 3'-deoxy-3'-(L-threonylamino)adenosine | 15 |
| COmetal | COBALT (II) ION | 14 |
| IOD | IODIDE ION | 14 |
| ADP | ADENOSINE-5'-DIPHOSPHATE | 13 |
| A3G | 3'-deoxy-3'-(glycylamino)adenosine | 10 |
| D3Y | 3'-deoxy-3'-(D-tyrosylamino)adenosine | 10 |
| REZ | (2R)-2-AMINO-7-{[(1R)-1-CARBOXYETHYL]AMINO}-7-OXOHEPTANOIC ACID | 5 |
| B07 | 2,6 DIMETHOXYBENZAMIDOBORONIC ACID | 4 |
| BH6 | {[(2-chlorobenzoyl)amino]methyl}boronic acid | 4 |
| BIY | (3S)-2,2-dimethyl-3,4-dihydro-2H-1,4-thiazine-3,6-dicarboxylic acid | 4 |
| EWA | [(1S)-1-{[(2,6-DIMETHOXYPHENYL)CARBONYL]AMINO}ETHYL]BORONIC ACID | 4 |
| EWB | [(1S)-1-{[(2-benzylphenyl)carbonyl]amino}ethyl](trihydroxy)borate(1-) | 4 |
| HQZ | trihydroxy{(1S)-1-[(methylsulfonyl)amino]ethyl}borate(1-) | 4 |
| NCF | (2R)-2-{(1R)-2-OXO-1-[(2-THIENYLACETYL)AMINO]ETHYL}-5,6-DIHYDRO-2H-1,3-THIAZINE-4-CARBOXYLIC ACID | 4 |
| REC | CEPHALOSPORIN | 4 |
| TFR | (2R)-2-amino-7-oxo-7-{[(2R,3S)-4,4,4-trifluoro-3-hydroxybutan-2-yl]amino}heptanoic acid | 4 |
| ZA3 | TRIHYDROXY-[[(2-NITROPHENYL)CARBONYLAMINO]METHYL]BORON | 4 |
| ZNmetal | ZINC ION | 4 |